Prostate cancer treatment costs in India

Best Prostate Cancer Treatment Cost in India

Prostate cancer is among the most commonly treated cancers by international patients in India — and it's also one of the areas where India's treatment options, technology access, and cost advantage are most compelling. For men diagnosed with prostate cancer who are weighing their treatment options, India offers the full spectrum of modern treatment — from robotic surgery to HIFU, SBRT, brachytherapy, and PSMA-targeted therapy — at costs that are typically 70 to 85 percent lower than in the US or UK.

 

What makes prostate cancer particularly suited to medical travel is the nature of most treatments: they are planned procedures, not emergencies. They can be scheduled, prepared for, and approached methodically — which is exactly how medical travel works best.

 

This article covers every treatment modality used for prostate cancer in India, what each costs, how treatments compare, and how to identify which option is most appropriate for your specific stage and risk profile.

Prostate Cancer Treatment Options in India — Overview

Treatment depends primarily on cancer stage and risk classification. The table below maps each stage to the available treatment approaches and the typical cost range in India:

 

Stage / Risk	Common Approach(es)	India Cost Range (USD)
Localised, Low Risk	Active Surveillance, HIFU, SBRT, Brachytherapy	$3,000 – $8,000 (if treating)
Localised, Intermediate Risk	Robotic Prostatectomy, EBRT+ADT, SBRT, Brachytherapy	$4,500 – $9,000
Localised, High Risk	Robotic Prostatectomy, EBRT+long-term ADT, or combination	$5,000 – $12,000
Locally Advanced (T3–T4, N0)	Radical Radiotherapy + long-term ADT	$6,000 – $14,000
Node Positive (N1)	Extended RT to pelvis + long-term ADT ± docetaxel	$8,000 – $18,000
Metastatic, Hormone Sensitive	ADT + docetaxel or novel hormone agents (abiraterone, enzalutamide)	$2,500 – $8,000 initial; then monthly medication cost
Castration-Resistant (mCRPC)	Enzalutamide / abiraterone / cabazitaxel / PSMA-targeted therapy	$3,000 – $15,000/month depending on agent

Robotic Radical Prostatectomy — Cost and What to Expect

Robotic-assisted radical prostatectomy — performed using the da Vinci surgical system — is the most commonly chosen surgical treatment for localised prostate cancer among international patients in India. It is the gold standard for surgical prostate cancer treatment globally, and India's robotic surgery programmes are among the most experienced in Asia.

 

Cost Component	India (USD)	USA (USD)
Robotic prostatectomy — surgeon + robot + OT	$3,500 – $6,000	$20,000 – $35,000
Hospital stay (3–5 days)	Included in most estimates	$5,000 – $10,000 separately
Pre-operative evaluation (bloods, ECG, scans)	$300 – $600	$1,500 – $3,000
Post-operative catheter management (1 week)	Minimal additional cost	Variable
Total all-in India estimate	$4,500 – $7,500	$25,000 – $50,000

 

The robotic approach offers several advantages over open surgery: smaller incisions, less blood loss, shorter hospital stay (typically 2 to 3 days), faster return to normal activity, and — in experienced hands — comparable or better outcomes for urinary continence and erectile function preservation.

 

Nerve-Sparing Prostatectomy For patients with localised disease and intact preoperative sexual function, nerve-sparing robotic prostatectomy offers the best chance of preserving erectile function post-surgery. This requires a surgeon experienced specifically in nerve-sparing technique — ask your surgeon directly about their nerve-sparing approach and outcomes data before committing to a procedure.

 

Radiation Therapy for Prostate Cancer — Options and Cost

Radiation therapy for prostate cancer has evolved significantly. Modern techniques deliver highly precise radiation to the prostate while minimising dose to surrounding structures — the rectum, bladder, and neurovascular bundles. India offers the full spectrum of radiation approaches:

 

Radiation Type	Sessions Required	India Cost (USD)	USA Cost (USD)
IMRT (standard, 7–8 weeks)	35–40 sessions	$3,000 – $6,000	$40,000 – $65,000
IGRT (image-guided)	35–40 sessions	$3,500 – $6,500	$45,000 – $70,000
VMAT / RapidArc	25–35 sessions	$3,500 – $6,500	$45,000 – $70,000
SBRT (5 sessions only)	5 sessions over 1–2 weeks	$4,500 – $9,000	$25,000 – $45,000
Proton Therapy	25–40 sessions	$15,000 – $25,000	$80,000 – $120,000+
LDR Brachytherapy (seed implant)	1 procedure	$4,000 – $7,000	$25,000 – $45,000
HDR Brachytherapy	1–2 procedures	$3,500 – $6,500	$20,000 – $40,000

 

SBRT: The Preferred Radiation Choice for International Patients

Stereotactic Body Radiation Therapy (SBRT) — also known as SABR — has become the most practical radiation option for international patients because it delivers the full radiation course in just 5 sessions spread over one to two weeks. Oncological outcomes data for prostate SBRT now equals conventional radiotherapy, and the compressed schedule means most patients can complete radiation treatment in India without an extended stay. India's leading centres including Apollo, Medanta, and HCG offer prostate SBRT.

HIFU — High Intensity Focused Ultrasound

HIFU uses focused ultrasound waves to heat and destroy prostate cancer cells without radiation or incision. It is a minimally invasive procedure performed under general or spinal anaesthesia, typically completed in a single session lasting 2 to 4 hours, with 1 to 2 nights in hospital.

 

Aspect	HIFU in India	Comparison
Procedure cost	$4,500 – $8,500	USA: $20,000 – $35,000; UK private: £15,000 – £25,000
Hospital stay	1–2 nights	Day procedure to 2 nights
Recovery time	1–2 weeks	Rapid — most patients mobile within 24–48 hours
Best suited for	Localised low-to-intermediate risk prostate cancer; salvage after failed radiation	Not recommended for large or high-risk tumours
Side effect profile	Lower incontinence risk than surgery; erectile function impact variable	Generally fewer severe side effects than surgery or radiation

 

HIFU is particularly suited to international patients because of its minimal recovery burden — most men can fly home within a week of the procedure. It is available at select centres in India including Apollo Hospitals and Medanta.

Hormone Therapy (Androgen Deprivation Therapy — ADT) Cost

Hormone therapy — androgen deprivation therapy (ADT) — is a cornerstone of prostate cancer treatment for locally advanced, node-positive, and metastatic disease. It is often used alongside radiation for high-risk localised cancer, and as primary treatment for metastatic disease.

 

ADT Type	India Cost (USD)	Notes
LHRH Agonist injection (leuprolide/goserelin, 3-monthly)	$150 – $400 per injection	Injected every 1, 3, or 6 months depending on formulation
LHRH Antagonist (degarelix, monthly)	$250 – $500 per injection	Monthly injection; faster testosterone suppression than agonist
Anti-androgen (bicalutamide, daily oral)	$30 – $80 per month	Often combined with LHRH agonist
Abiraterone (Zytiga, oral)	$200 – $600 per month	For metastatic castration-resistant disease; USA $8,000–$12,000/month
Enzalutamide (Xtandi, oral)	$300 – $800 per month	For mCRPC; USA $10,000–$15,000/month
Darolutamide (Nubeqa, oral)	$300 – $700 per month	Newer agent, fewer CNS side effects
Apalutamide (Erleada, oral)	$300 – $700 per month	For non-metastatic CRPC and metastatic HSPC

 

Long-Term ADT: India's Biggest Financial Advantage For men on long-term ADT with enzalutamide or abiraterone, the monthly cost in the US is $8,000 to $15,000. In India, the same drugs cost $200 to $800 per month. Over a 12-month period, this represents a saving of $90,000 to $170,000. Many international patients specifically travel to India to stock up on their oral hormone therapy medications, returning home with several months' supply prescribed by their treating oncologist.

PSMA-Targeted Therapy and Lutetium-177 PSMA

Lutetium-177 PSMA therapy (Lu-177-PSMA) is one of the most significant recent advances in prostate cancer treatment — a form of targeted radionuclide therapy that delivers radiation directly to PSMA-expressing prostate cancer cells throughout the body. It is approved for metastatic castration-resistant prostate cancer (mCRPC) and has shown meaningful survival benefit in clinical trials.

 

• India has developed a strong PSMA therapy programme, with the drug manufactured domestically under BARC (Bhabha Atomic Research Centre) oversight
• PSMA PET-CT scan — required before treatment to confirm PSMA expression and assess disease extent — costs $400 to $800 in India, compared to $3,000 to $5,000 in the US
• Each cycle of Lu-177-PSMA therapy costs approximately $3,500 to $6,000 in India; a typical course involves 4 to 6 cycles delivered every 6 weeks
• Full course cost for 6 cycles in India: approximately $21,000 to $36,000, versus $100,000 to $200,000+ in the US
• Available at Apollo Hospitals, Fortis, and several nuclear medicine centres with dedicated radionuclide therapy programmes

Prostate Cancer Staging and Diagnostics in India

Accurate staging is essential before any treatment decision. The following tests are typically required and are significantly cheaper in India than in Western countries:

 

Diagnostic Test	India Cost (USD)	USA Cost (USD)
PSA (Prostate Specific Antigen) test	$10 – $25	$50 – $150
TRUS-Guided Biopsy (12-core)	$300 – $600	$2,000 – $5,000
MRI-Targeted (Fusion) Biopsy	$600 – $1,200	$4,000 – $8,000
Multiparametric MRI Prostate (mpMRI)	$300 – $600	$2,000 – $4,000
PSMA PET-CT Scan	$400 – $800	$3,000 – $5,000
Bone Scan (Technetium)	$100 – $200	$800 – $2,000
CT Chest / Abdomen / Pelvis (staging)	$150 – $300	$1,500 – $3,000
Gleason Score / Pathology Review	$100 – $250	$500 – $1,500

 

PSMA PET-CT: India's Diagnostic Advantage PSMA PET-CT is the most accurate staging scan for prostate cancer — far superior to conventional bone scans and CT for detecting metastatic disease. In the US, access remains limited and cost is high. In India, PSMA PET-CT is widely available at private nuclear medicine centres at under $800. For patients coming to India for a second opinion or treatment planning, starting with a PSMA PET-CT provides the most accurate disease mapping available.

Realistic Total Cost Scenarios — By Stage

These scenarios represent realistic all-in treatment costs for a patient traveling to India, covering the primary treatment modality plus standard associated diagnostics and follow-up:

 

Scenario 1: Localised Low-Risk Prostate Cancer — Active Surveillance or HIFU

Item	Estimated Cost (USD)
mpMRI + PSMA PET-CT (baseline staging)	$700 – $1,400
HIFU procedure (if treating) + 2 nights hospital	$4,500 – $8,500
Post-procedure PSA monitoring (6-monthly)	$10 – $25 per test
Total (HIFU route)	$5,200 – $10,000

 

Scenario 2: Intermediate-Risk Localised — Robotic Prostatectomy

Item	Estimated Cost (USD)
mpMRI + pre-op evaluation	$500 – $900
Robotic prostatectomy + 3-night hospital stay	$4,500 – $7,000
Post-op pathology (surgical specimen)	$100 – $250
Post-discharge PSA monitoring	$10 – $25 per test
Total	$5,200 – $8,200

 

Scenario 3: High-Risk Localised — SBRT + Long-Term ADT

Item	Estimated Cost (USD)
PSMA PET-CT + staging	$600 – $1,000
SBRT (5 sessions over 1–2 weeks)	$4,500 – $9,000
ADT (LHRH agonist, 2–3 years; 3-monthly injection)	$150–$400 per injection × 8–12 injections
Total treatment period cost	$7,000 – $15,000

 

Scenario 4: Metastatic Castration-Resistant — Lu-177-PSMA Therapy

Item	Estimated Cost (USD)
PSMA PET-CT (baseline + post-treatment response)	$400–$800 × 2 scans
Lu-177-PSMA therapy (6 cycles, every 6 weeks)	$3,500–$6,000 per cycle
Concurrent enzalutamide (oral, 9 months)	$2,700–$7,200
Total (full course)	$24,800 – $47,600

 

How to Decide Which Treatment Is Right for You

Prostate cancer has multiple effective treatment options for most stages, and the 'best' option is not the same for every man. The decision depends on several factors:

 

• Stage and risk classification (low / intermediate / high risk based on PSA, Gleason score, and clinical T stage)
• Age and overall health — younger men with a long life expectancy may lean toward surgery; older men toward radiation
• Priorities regarding side effects — surgical incontinence risk vs radiation's bowel and urinary side effects vs HIFU's side effect profile
• PSA doubling time and Gleason grade — higher grade disease warrants more aggressive treatment
• Whether the cancer is localised, locally advanced, or metastatic — this determines the range of curative versus palliative options
• Prior treatment history — for recurrent disease after prior surgery or radiation, different options apply

 

India's oncology centres approach prostate cancer with multidisciplinary tumour boards — urological oncologist, radiation oncologist, and medical oncologist together reviewing each case. This ensures your treatment recommendation reflects collective specialist input rather than a single specialty's bias.

Frequently Asked Questions

Is PSMA PET-CT available across India or only in major cities?

PSMA PET-CT is available at nuclear medicine departments in major cities — Delhi, Mumbai, Chennai, Hyderabad, Bengaluru — at most large private hospitals and several government centres. It is not yet available in smaller cities. For international patients, this is rarely an issue since treatment centres are almost always in major metros.

 

Can I have robotic prostatectomy if I am over 70?

Age alone is not a contraindication. Suitability for robotic prostatectomy in older patients depends on overall fitness, comorbidities, and life expectancy rather than age per se. Your oncology team will assess surgical fitness comprehensively before recommending surgery. Many men in their 70s with localised prostate cancer are excellent surgical candidates.

 

How long will I need to stay in India for prostate cancer treatment?

It depends on the treatment. Robotic prostatectomy requires 2 to 3 nights in hospital plus about 1 week of recovery in India before flying — total approximately 10 to 14 days. HIFU is similar — 1 to 2 nights in hospital, 7 to 10 days total. SBRT radiation requires staying in India for 1 to 2 weeks across 5 treatment sessions. ADT injections can be received during a short visit every 3 months. Lu-177-PSMA requires return visits every 6 weeks for 4 to 6 cycles.

 

Will my PSA follow-up monitoring after treatment be manageable from home?

Yes. PSA monitoring requires a simple blood test every 3 to 6 months, available at any local laboratory in your home country. Your Indian treating oncologist will specify the target PSA values and follow-up schedule in your discharge documentation, and your home doctor can manage the monitoring and flag any concerning results.

 

What if prostate cancer returns after initial treatment in India?

Biochemical recurrence after prostatectomy or radiation is a defined clinical situation with established management pathways. If PSA rises after initial treatment, your Indian oncologist remains available for remote consultation, and you can return for a PSMA PET-CT and salvage treatment assessment. Salvage radiation after prostatectomy, or salvage hormone therapy after radiation, are both available in India at the same cost advantages as primary treatment.

Get Your Free Prostate Cancer Treatment Assessment

The right treatment for prostate cancer depends on your PSA level, Gleason score, staging, and personal priorities regarding side effects and lifestyle. Share your biopsy report, PSA history, and any staging scans you have — our oncology team will assess your case and recommend the most appropriate treatment approach, with a written cost estimate, within 24 to 48 hours.

 

Get a Free Prostate Cancer Assessment and Cost Estimate PSA results, biopsy report, and staging scans reviewed within 24–48 hours. No obligation.

 

 

Racure Healthcare  |  International Patient Services  |  www.racurehealthcare.com

Connecting patients worldwide with India's finest oncology specialists.